INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (102573, 681, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c8d575d93db3414fd2b9a7da2d36477b3db16e8db52a0143a8569f346763ab27d6d8b952523c9092ec37fe7dc2bdbc9a6c0f0b293c4f2fd38f79c73b57f5e5461683e3addd1c54b75d1eb5e1b77b15217ae78f8682afeeddd373fbdd8dcde7cf525ff3c04cbbfb529f5f1e5d5d5e170b87465612e9ded2e9d692f1bbfbf2abc7f8857cb6b57fc5e2c83eea9faa813bf7e737df3627dbd596f36dbcdf397b7cf5f3e97e091ca64bc8b38f2e745698d33a5b61fa3699ca9f1d19552e34fa6aad49d4ba6f095a1a8b4abd4366817eb21e26df59e740eb3733b2787f57278a5fa603a1d8c1d95af556a49bd695eab34f6b4523a909ab3e2f9316f921c9d1e5541ea40fa61a5e88fd6142619d7a8ca47dd90a2ba46f9f152bda908f9ea919fc5a16c4fd24b8c40bf0f06a9c87d1a3b5229904e1d4d49f40155388a51ca3be92a52d89b9210ffac2529db74bd45a5892a659c2a7c42d6724824312bb27ac493963a6fc764ca4781c30cd7e5cefd7a7b7dbf73778f5ac7f38863b50f4ba01fb6efa33251e0c3580da760e088934f958d2a994441597f507875701525e0a30b4bcad29e6ce4c31ca1b73a765ae99a8f03fd64b455a5770975ad7056578c64f24a03843d056e4a77c0883b99abe760a58ec4b0055a477211813e697e76296c59fff8a0b968e3f6deee33501ee19477b44ead0915bffb3fb1525f30064f04b20d433627389b4ba0d8e3b8e1ae19c1ced86a9dfc7a6ac4741d550663cb900a01e4ad66b03a80833a465f1a99ebc160a8a71358a9436b402fe614a3c410796b9a2118bd420c07186b6dec1098db088d9c0e11746a17440a4644dbe8cf18546a34ccfc9d00ff8c4b47d6cca16e6781a0cf8ea3d499a96eb056f51804289e4199119d9b22fce139d4eac7872ff4d36237dcdc6c6e9eace46bfe523cc557e0970f3c7da2fa969c67d99e16d0ea8802d0641f3cf70a40b8113a879dd1834e5d9627d306606a86ddc414c4198ea517d67bf4ed9d0f42fa5e07ddf9c1a54bb515fe07932633e1a7735d8ca2a33c444469ac2f308fdef7986ca650a71fc01293e025f0808e70b232355437d8c4a52f30e5326708ffc16072712b5586d1f7a01cac4272e4b1f33c24298e07c65f8e33460d3ac99e040da24ea7603c1c1b95066f49e87d73cf3efac3a2876f4da44968acdeef290d99b9efe850f8e01eb96e432ecebc38d7c2cc31c0e32184c14d7265e4d045e3d87d6aeab4e5f11443927c4761568f0ba997425c2e441c6aecb39bef86eb6b7dcd3c58651d08f3c47e1830ac168ea315f831aad6346db6af8ca0773c45643864b24c22ed7d805c04a4db7bfefb4ca0fa4533880d18fd76ecfad69723b4f3617455f01df181bb934848da2fe7edf17c9ccee7a5a4452cc528989efb4ced01e08191ec29181030e899b53c6382a332da04167233d6b0e909b93075b8ec8cb98028b1d6430f22a33eb618160c1e8da8c2f1181943a6e7e2c5953c991d28cf279abc4e9e0b2e2fee17529cededf7e252dba5987f58d950f59eb2ac63eb0f27aad64d83d945f47362502db417f2d7075339d47d6c1533fb6dba62e022e0237311a21b48e486f6a1fea14c0303180d1acdda2e281d383d8c544fd178f221b7f088ebdcf4e6d9e38550cd532b2050245d8b7766027e1e721ac4b1680c3e37b2ca1cee7dca12b5e3e9725c5a635b02f36be3e41173194ba14dd3ba86ac177f5b140adfec0c9b02de4cbef41d9b4d612c77bf1c326e5a2a67dc11270d54f21526a6215fb3606b2882f686bd0a9975622a3912ee09a778f1202b567f8285cd18676f62d026bf7b5ce94afa418cb2e5eb601423318e914bf9e2605c6d75d76556b3786a787535c32ac1062739658b95a6cfaeca3cfd52d8fa95b0f5c3db579b67779b9d7b8daaa5a06facae2aa47ec599039ff99915f0472f2444b6c988ce67aa50389d0494f5ca21d627dbbd3645f0056e424996ccf9de1f5cadf73ec8ed69bea22a3f248c8a6432cb82e5e39928c5546f4e36d1826b1143e625413c78ad1646a9a44343e9086a4d815104aff6a0026f5afc9e2fbed2ef49576be8093fefe93f9b9365946793dae007f8ec87eddd76c3bbfdc3f6cdbbd7dc487b407db9146630bbcb7c9f132b528f3b136b8b620b6c3ecc2edd8f32d0af6594dfc9cd1c2eaeb63ea1cb572d4410d19eb7eaad5c4565e0ecb6137fb1569b06473271594920f2807b926a7de73f8d8d1f32f558e1e24f132d9324284f124c775dd154a02a8f866f6a5c67ccfb051f770efeb073cb7824285f496049a6145c69698331d8c39bf4245126debf24c6cc6c6a05e82cbb0346eefc4930ae7c5d09be3014831b4a001f98a427c13c6f0cd3d8117843d2a85bcc24ff6b70bc7679e06765e4e8b0a0cf0ae5f67830cfaeef2ffefaeb6f749845af', 'NCBI', 1768159683, 1768159683, NULL, NULL, NULL, NULL, NULL, NULL, NULL);